The Current State of Pediatric Functional Neurological Disorder Treatment in the United States

Meagan Watson1, Jason Kreuzman2, Karen Zeribi3

  • 1Department of Neurology, University of Colorado, Aurora, Colorado.

Pediatric Neurology
|July 26, 2024
PubMed

Insights

Pediatric functional neurological disorder (FND) treatment is available nationwide, but care varies significantly. Research is needed to standardize effective, accessible FND care for children and adolescents.

Area of Science:

  • Neurology
  • Child Psychiatry
  • Pediatric Healthcare

Background:

  • Pediatric functional neurological disorders (FNDs) are prevalent yet under-researched.
  • Existing FND treatment programs lack comprehensive data.
  • This study addresses the need for understanding pediatric FND care in the US.

Purpose of the Study:

  • To define the current landscape of pediatric FND treatment in the United States.
  • To identify available treatment programs, care team composition, and treatment modalities.
  • To assess aftercare management strategies for pediatric FND.

Main Methods:

  • A survey was conducted by the Functional Neurological Disorder Society (FNDS) Pediatric Special Interest Group (SIG).
  • Information was gathered from 39 care team members across 24 healthcare centers in 16 states.
  • Data on treatment settings, patient demographics, and therapeutic approaches were collected.

Main Results:

  • 31 unique pediatric FND treatment settings were identified, primarily outpatient (62%).
  • Psychologists were the most common specialists (52%), with most centers treating ages 6-21 and all FND symptoms.
  • Cognitive behavioral therapy (77%) and personalized approaches (58%) were common, alongside strong school (97%) and caregiver (94%) involvement.

Conclusions:

  • Pediatric FND treatment is accessible across the US, but significant variability exists in care delivery.
  • Differences in care team composition, treatment strategies, and aftercare management were observed.
  • Further research is essential to develop standardized, effective, and sustainable treatments to enhance access to care for pediatric FND patients.
Abstract